P. Heumann, A. Albert, M. Müller-Schilling, A. Kandulski
{"title":"Budesonid是用以治疗肺部测量器的新方法,由一家患有胃门炎的病人服用肝炎。","authors":"P. Heumann, A. Albert, M. Müller-Schilling, A. Kandulski","doi":"10.1055/s-0043-1764106","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":256664,"journal":{"name":"50. Jahrestagung der Gesellschaft für Gastroenterologie in Bayern e.V.","volume":"9 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Budesonid als neue Option zur Behandlung einer Immuncheckpoint-Inhibitor (ICI)- vermittelten Hepatitis bei einem Patienten mit Adenokarzinom des Magens.\",\"authors\":\"P. Heumann, A. Albert, M. Müller-Schilling, A. Kandulski\",\"doi\":\"10.1055/s-0043-1764106\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":256664,\"journal\":{\"name\":\"50. Jahrestagung der Gesellschaft für Gastroenterologie in Bayern e.V.\",\"volume\":\"9 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"50. Jahrestagung der Gesellschaft für Gastroenterologie in Bayern e.V.\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0043-1764106\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"50. Jahrestagung der Gesellschaft für Gastroenterologie in Bayern e.V.","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0043-1764106","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Budesonid als neue Option zur Behandlung einer Immuncheckpoint-Inhibitor (ICI)- vermittelten Hepatitis bei einem Patienten mit Adenokarzinom des Magens.